Sarepta Q2 FY26 net income turns to USD 4.89 million loss; revenue drops 34% to USD 401.25 million

Reuters2026/08/05 20:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sarepta Therapeutics posted a net loss of $4.89 million, swinging from net income a year earlier, as revenue fell 34% to $401.25 million.
Product revenue dropped 36% to $328.69 million, driven by a 65% slide in ELEVIDYS revenue to $98.13 million; PMO Products were flat at $230.56 million.
Operating income narrowed to $13.29 million from $115.58 million, reflecting the revenue decline and a $39 million litigation contingency charge.
Research and development expense fell 55% to $91.26 million, while selling, general and administrative costs declined 22% to $107.6 million.
Cash, cash equivalents, restricted cash and investments totaled $944.99 million at June 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-335003), on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sarepta Q2 FY26 net income turns to USD 4.89 million loss; revenue drops 34% to USD 401.25 million

You may also like

Crypto prices